NTLA vs. BATT
NTLA (Intellia Therapeutics, Inc.) is a stock, while BATT (Amplify Lithium & Battery Technology ETF) is Lithium & Battery Metals fund actively managed by Amplify. Over the past 5 years, NTLA returned -29.38%/yr vs 1.08%/yr for BATT. At a 0.44 correlation, their price movements are largely independent.
Performance
NTLA vs. BATT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NTLA achieves a 69.63% return, which is significantly higher than BATT's 14.35% return.
NTLA
- 1D
- -3.17%
- 1M
- 21.03%
- YTD
- 69.63%
- 6M
- 61.89%
- 1Y
- 65.22%
- 3Y*
- -28.07%
- 5Y*
- -29.38%
- 10Y*
- -5.26%
BATT
- 1D
- -5.00%
- 1M
- -5.57%
- YTD
- 14.35%
- 6M
- 13.17%
- 1Y
- 80.97%
- 3Y*
- 10.67%
- 5Y*
- 1.08%
- 10Y*
- —
NTLA vs. BATT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
NTLA Intellia Therapeutics, Inc. | 69.63% | -22.90% | -61.76% | -12.61% | -70.49% | 117.35% | 270.82% | 7.47% | -49.54% |
BATT Amplify Lithium & Battery Technology ETF | 14.35% | 59.70% | -13.93% | -7.05% | -32.25% | 16.52% | 44.43% | -2.40% | -42.27% |
Correlation
The correlation between NTLA and BATT is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.40 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.45 |
Correlation (All Time) Calculated using the full available price history since Jun 6, 2018 | 0.44 |
The correlation between NTLA and BATT shifts across timeframes, from 0.35 (1 year) to 0.45 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NTLA vs. BATT — Risk / Return Rank
NTLA
BATT
NTLA vs. BATT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Intellia Therapeutics, Inc. (NTLA) and Amplify Lithium & Battery Technology ETF (BATT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NTLA | BATT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.83 | ||
| Sortino ratioReturn per unit of downside risk | -1.39 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.39 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 0.92 | 4.78 | -3.86 |
| Martin ratioReturn relative to average drawdown | 1.41 | 15.62 | -14.21 |
Loading charts...
Drawdowns
NTLA vs. BATT - Drawdown Comparison
The maximum NTLA drawdown since its inception was -96.45%, which is greater than BATT's maximum drawdown of -69.38%. Use the drawdown chart below to compare losses from any high point for NTLA and BATT.
Loading charts...
Drawdown Indicators
| NTLA | BATT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.45% | -69.38% | -27.07% |
Max Drawdown (1Y)Largest decline over 1 year | -71.27% | -17.03% | -54.24% |
Max Drawdown (3Y)Largest decline over 3 years | -86.28% | -47.65% | -38.63% |
Max Drawdown (5Y)Largest decline over 5 years | -96.45% | -61.98% | -34.47% |
Max Drawdown (10Y)Largest decline over 10 years | -96.45% | — | — |
Current DrawdownCurrent decline from peak | -91.37% | -12.48% | -78.89% |
Average DrawdownAverage peak-to-trough decline | -57.19% | -34.60% | -22.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.34% | 5.20% | +41.14% |
Volatility
NTLA vs. BATT - Volatility Comparison
Intellia Therapeutics, Inc. (NTLA) has a higher volatility of 29.47% compared to Amplify Lithium & Battery Technology ETF (BATT) at 12.72%. This indicates that NTLA's price experiences larger fluctuations and is considered to be riskier than BATT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NTLA | BATT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.47% | 12.72% | +16.75% |
Volatility (6M)Calculated over the trailing 6-month period | 58.34% | 27.15% | +31.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 98.89% | 32.69% | +66.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 81.41% | 29.95% | +51.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.80% | 30.76% | +48.04% |
Dividends
NTLA vs. BATT - Dividend Comparison
NTLA has not paid dividends to shareholders, while BATT's dividend yield for the trailing twelve months is around 1.62%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BATT Amplify Lithium & Battery Technology ETF | 1.62% | 1.85% | 3.17% | 3.23% | 4.14% | 2.32% | 0.21% | 3.22% | 0.89% |
NTLA Intellia Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
NTLA and BATT have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NTLA has higher volatility (29.47%) compared to BATT (12.72%). In terms of maximum drawdown, NTLA dropped -96.45% vs BATT's -69.38%.
BATT currently has the higher Sharpe Ratio (2.49 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NTLA and BATT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer